| HS Code | 202461 |
| Name | Cepharanthine |
| Cas Number | 481-49-2 |
| Molecular Formula | C37H38N2O6 |
| Molecular Weight | 606.71 g/mol |
| Appearance | Yellowish crystalline powder |
| Solubility | Slightly soluble in water; soluble in ethanol and chloroform |
| Melting Point | 205-210°C |
| Usage | Alkaloid with potential anti-inflammatory and antiviral effects |
| Origin | Natural bisbenzylisoquinoline alkaloid extracted from Stephania plants |
| Mechanism Of Action | Inhibits membrane lipid peroxidation and modulates immune response |
| Storage Conditions | Store at room temperature, away from light and moisture |
| Synonyms | Cepha, Kurramine, Oraphenine |
| Pharmacological Class | Alkaloid |
| Iupac Name | 5,6,7,8,15,16,17,18-Octahydro-2,10-dimethoxyberbine-1,19-diol |
As an accredited Cepharanthine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Cepharanthine is packaged in a sealed amber glass vial, labeled clearly, containing 1 gram of fine, off-white powder for research use. |
| Shipping | Cepharanthine is shipped in secure, moisture-proof, and light-resistant packaging to maintain its stability and quality. It is typically transported at room temperature unless otherwise specified, and labeled according to international chemical safety standards. Documentation accompanies each shipment to ensure traceability and regulatory compliance during transit. |
| Storage | Cepharanthine should be stored in a tightly sealed container, protected from light, moisture, and air. Keep it at room temperature (15–25°C or 59–77°F) in a dry, well-ventilated area, away from incompatible substances, heat, and ignition sources. Proper storage ensures chemical stability and prevents degradation or contamination. Always follow the manufacturer’s guidelines and local regulations for safe storage. |
Competitive Cepharanthine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Cepharanthine reflects decades of hands-on attention, careful process refinement, and the kind of persistent problem-solving only those working in actual plant floors and production lines can know. In this introduction, we hope to open a window into our journey with cepharanthine, focusing on its model, unique specifications, uses in the field, and the important distinctions separating it from similar products on the market.
We have produced cepharanthine for years, developing a routine that begins with controlled cultivation of raw Stephania cepharantha roots. This first step matters, since natural variation in roots harvested from different regions and under different weather conditions plays a significant role in consistency. Through a mix of skilled manual sorting and automated optical screening, we address these biological differences and weed out substandard lots. Every person working on extraction and purification has seen how early-stage selection can make or break the final outcome, especially for batch yield and repeatability.
Our standard cepharanthine product comes as a fine, off-white powder, carefully dried and packed to maintain stability in transport and storage. Internal quality benchmarks demand purity over 98%, checked with HPLC and cross-validated with NMR and MS. These levels do not happen by chance. During pilot runs, trace contaminants would carry through from the root, so we built in a two-step purification workflow, entailing silica gel column separation followed by a high-resolution recrystallization. We found this extra measure crucial for customers needing uninterrupted purity across seasons and batches.
In research and pharmaceutical sectors, cepharanthine only earns respect when its batch quality does not throw off formulation or results. Early in our journey, customers approached us reporting unexplained impurities in competitor samples. These contributed to cloudiness in solutions or skewed activity assays in preclinical environments. Our practice now locks down both active compound content and tight impurity profiles because drug development and analytical work cannot tolerate the surprise of variable chemical background. It saves on time, cuts waste, and, more broadly, gives scientists and manufacturers confidence in their own production schedules. We share analytical certificates with each consignment, detailing the lot-testing summary so users can verify the controls for themselves.
Cepharanthine finds its way into pharmaceutical pipelines, natural therapy research, cellular biology, and even veterinary health. For example, compound screening teams often switch to our cepharanthine after regular experiences with unwanted byproduct peaks from other sources. In oncology, compound-editing teams highlight reliable action at the cell membrane, calling out differences that seem subtle on paper but show clear advantages during pharmacology runs. Pharmaceutical groups in early formulation phases value our presentation of the physical powder: its density, how it dissolves, and how cleanly it passes the filter after solubilization.
We receive steady requests for custom mesh sizes or with specific residual solvent standards. Having full control over our line, we can dovetail to these requirements without introducing outside agents or third-party involvement, ensuring a secure supply chain. The transparency in our manufacturing, tested specifications, and openness to feedback sets our cepharanthine apart from generic intermediaries offering unverified powder.
It’s easy to group cepharanthine with other bisbenzylisoquinoline alkaloids, but details in manufacturing, crystallization quality, and control strategies create sharp differences in practice. Some manufacturers cut corners on initial extraction, resulting in higher levels of cationic impurities, plant debris, or even pesticide residues. We take deliberate steps to inspect for heavy metals, mycotoxins, and plant-specific contaminants since these issues slip through basic processing. We learned this lesson after discovering unexpected peaks in batch QC analytics. Now our entire extraction line uses upgraded filtration and cleaning protocols, and we monitor water and all handling equipment.
Another key difference comes in the form of polymorphic presentation. During our development phase, we mapped out crystallization conditions for our cepharanthine product to reduce unwanted hydrate forms or aggregation. This work took many months and close coordination between our analytical team and plant operators. With this, clients experience fewer challenges during formulation or dissolution, and receive a powder with narrow specifications on flow, density, and moisture.
Some products on the market use shortcuts in the drying phase, producing a powder that clumps or takes up moisture in humid climates. Through our in-house drying rooms, which operate at strictly controlled temperature and humidity ranges, those issues do not show up in our lots. These physical traits, often ignored by resellers and third-parties, turn out essential for anyone planning scale-up or precise weighing in high-throughput settings.
Technological advances in extraction and purification shape the way we deliver cepharanthine to our partners. We invested in in-line process monitoring to spot early drift in process parameters. This means, for example, that if solvent exchange steps show a variance from set points, plant managers receive immediate alerts, and the lot in question receives added attention. Batch traceability supports transparency with end users, especially in regulated pharmaceutical environments. We maintain records not just of source plant and extraction dates, but of every analytical and environmental test result across each stage.
Requests for higher-grade cepharanthine drive us to fine-tune every aspect from temperature profiles during extraction to methods for minimizing oxidative breakdown. Customers engaged in injectable or oral drug development review our manufacturing notes during their audits, confirming for themselves the absence of phthalates, silica dust, or other problematic carry-overs. Our open-door approach to quality audits grew from hard lessons learned in the early days, when minor oversights delayed customer drug-approval filings.
We frankly admit that problems arise. Every chemical plant sees its share of hiccups, defects, or feedback from the field about practical challenges. We instituted a system for recording and analyzing these events, so improvements can build incrementally. In one instance, a veterinary client reported faint but stubborn off-odors when formulating pastes. Our trace-back revealed an interaction with one of our storage containers; we changed suppliers and foodsafe certified all storage kits. That same year, we expanded our odor and volatile-screening panel for all outgoing cepharanthine shipments.
This drive, rooted in firsthand lessons, keeps our cepharanthine development relevant. We work closely with academic and industrial users, who share their needs for specialty packaging, moisture-resistant containers, or even controlled particle reduction for advanced delivery systems. These partnerships expand the reach and applicability of what might otherwise become a static product, making sure it continues to match current expectations.
We act with a sense of responsibility about everything upstream and downstream of our manufacturing. We source plant material from audited farms, actively avoiding overharvesting or problematic supply chains that can undermine the sustainability of sourcing Stephania cepharantha. For waste management, we target solvent recovery rates above 99%, investing in closed-loop reclamation kits instead of older open-processing alternatives. Community and regulatory feedback together shape how we certify each batch, including tests for residues banned under local or global guidelines.
Pharmaceutical and nutraceutical trends place higher expectations on transparency, not just product performance. We share our full supply chain audits with long-term partners, even hosting site visits and virtual walkthroughs of our processing lines. This type of visibility builds trust between ourselves and those using our cepharanthine in research, pilot manufacture, or commercial drug development.
Working as direct manufacturers shapes our daily experience. We know everyone working hands-on in extraction, instrumentation, and packing. This direct oversight lets us identify sources of batch-to-batch drift fast. When customers raise concerns or request changes, we don’t send the question up a bureaucratic chain or push it onto someone else—our technical, quality, and production staff handle it on the ground, with clear ownership. This speeds up problem-solving, supports rapid adaptation, and closes the distance between process and final product.
Everything we learn about cepharanthine and its applications gets fed back into the plant floor, so next batches reflect user feedback, new scientific findings, and changes in material supply or regulation. This cycle of improvement could not happen if we operated as a reseller or bulk trader, far from the actual machines and people involved.
Researchers and industry experts consistently raise new possibilities for cepharanthine: from anti-inflammatory and immune-modulating functions, to antiviral discovery projects prompted by global health needs. To help, we make ourselves available to discuss specific formulation or development goals—sharing details on solubility, batch characteristics, and what to expect during scale-up. These conversations often identify overlooked variables, such as interactions of cepharanthine with certain excipients during process development, or how its unique molecular profile can alter stability in finished formulations. By remaining a direct and engaged supplier, we can respond with flexibility based on what happens in the real world, not only what fits a narrow specification sheet.
Some customers run long-term storage or stress-stability studies in demanding climates, such as high temperature or fluctuating humidity. Drawing on feedback, we improved our sealing protocol and moved to foil-lined, argon-flushed containers to guard against product breakdown. Pharmacists and formulation chemists now notice longer shelf lives and steadier physical properties.
Used smartly, cepharanthine serves as more than an ingredient in a controlled setting. It generates ripple effects throughout development, manufacturing, and finally, to the patients or animals who may benefit from its properties. Getting this molecule right takes more than the use of up-to-date equipment or adherence to an official guideline. You need hands in the raw material, eyes on the analytics, and a willingness to chase problems back to their source.
We believe choosing where your cepharanthine comes from means picking between generic commodity handling and production deeply shaped by practical experience. On our side, every kilogram processed comes with a commitment—you interact with people who have watched this product evolve from raw herb to finished batch, monitored its effects across different client settings, and improved it through real-world feedback.
Managing cepharanthine production as a hands-on manufacturer builds a product that stands up under regulatory examination and close scientific scrutiny. The distinctions between our cepharanthine and anonymous powders sourced through disconnected supply chains are not just philosophical or marketing claims. Every step, from raw herb selection to analytical clearance and batch documentation, grows out of lived experience. Problems get seen, discussed, and corrected by the same crew that handles every extraction and purification run.
Our cepharanthine has found its way into diverse clinical trial lots, research-scale test runs in universities, and even niche veterinary health projects. Each one leaves a trace of learnings, times where our own process had to adapt, or moments when a unique use highlighted an overlooked quality of the powder.
On our plant floor, every operator and analyst puts care and attention into their part of each batch. This focus transmits into the performance of the cepharanthine that ends up in research labs, pharmaceutical plants, or experimental drug trials. We put our names behind our work, confident the difference in dedication and process control will be clear to those who depend on the product day in and day out.
If you value supply chain clarity, batch stability, and open communication across the development process, our direct approach to cepharanthine manufacturing lines up with your goals. We invite you to dig deeper, compare processes, and see for yourself how our methods stand out in a market crowded with untraceable intermediaries. Every batch holds the story and knowledge from decades of collective effort, learning, and honest industry work.